Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 13, 2019

SELL
$3.71 - $4.83 $83,660 - $108,916
-22,550 Closed
0 $0
Q1 2019

May 10, 2019

SELL
$3.2 - $4.19 $8,480 - $11,103
-2,650 Reduced 10.52%
22,550 $94,000
Q4 2018

Feb 14, 2019

SELL
$2.8 - $4.22 $24,080 - $36,292
-8,600 Reduced 25.44%
25,200 $86,000
Q3 2018

Nov 07, 2018

BUY
$3.5 - $4.91 $45,500 - $63,830
13,000 Added 62.5%
33,800 $145,000
Q2 2018

Aug 13, 2018

BUY
$3.22 - $4.43 $27,370 - $37,655
8,500 Added 69.11%
20,800 $77,000
Q1 2018

May 11, 2018

BUY
$4.05 - $6.46 $49,815 - $79,458
12,300 New
12,300 $52,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $539M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Mml Investors Services, LLC Portfolio

Follow Mml Investors Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.